Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11EUR
205.22 MEUR
1.48 BEUR
285.21 M
About PHARMARON BEIJING
Sector
CEO
Bo Liang Lou
Website
Headquarters
Beijing
Employees (FY)
20.3 K
Founded
2004
ISIN
CNE100003PG4
FIGI
BBG00R83LKL4
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services. The company was founded by Bo Liang Lou, Xiao Qiang Lou and Bei Zheng on July 1, 2004 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 17Q1 is 1.08 EUR — it has increased by 3.85% in the past 24 hours. Watch PHARMARON BEIJING H YC1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PHARMARON BEIJING H YC1 stocks are traded under the ticker 17Q1.
17Q1 stock has fallen by 3.57% compared to the previous week, the month change is a 0.93% rise, over the last year PHARMARON BEIJING H YC1 has showed a 52.35% decrease.
We've gathered analysts' opinions on PHARMARON BEIJING H YC1 future price: according to them, 17Q1 price has a max estimate of 3.54 EUR and a min estimate of 0.94 EUR. Watch 17Q1 chart and read a more detailed PHARMARON BEIJING H YC1 stock forecast: see what analysts think of PHARMARON BEIJING H YC1 and suggest that you do with its stocks.
17Q1 reached its all-time high on Jun 28, 2021 with the price of 10.13 EUR, and its all-time low was 0.000444 EUR and was reached on Jul 17, 2007. View more price dynamics on 17Q1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
17Q1 stock is 3.70% volatile and has beta coefficient of 1.83. Track PHARMARON BEIJING H YC1 stock price on the chart and check out the list of the most volatile stocks — is PHARMARON BEIJING H YC1 there?
Today PHARMARON BEIJING H YC1 has the market capitalization of 2.07 B, it has decreased by 2.63% over the last week.
Yes, you can track PHARMARON BEIJING H YC1 financials in yearly and quarterly reports right on TradingView.
PHARMARON BEIJING H YC1 is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
17Q1 earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.03 EUR resulting in a −39.73% surprise. The estimated earnings for the next quarter are 0.03 EUR per share. See more details about PHARMARON BEIJING H YC1 earnings.
PHARMARON BEIJING H YC1 revenue for the last quarter amounts to 341.61 M EUR despite the estimated figure of 371.65 M EUR. In the next quarter revenue is expected to reach 394.01 M EUR.
17Q1 net income for the last quarter is 29.70 M EUR, while the quarter before that showed 57.94 M EUR of net income which accounts for −48.74% change. Track more PHARMARON BEIJING H YC1 financial stats to get the full picture.
Yes, 17Q1 dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 2.23%. Tracking PHARMARON BEIJING H YC1 dividends might help you take more informed decisions.
PHARMARON BEIJING H YC1 dividend yield was 1.37% in 2023, and payout ratio reached 21.64%. The year before the numbers were 0.61% and 24.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 2, 2024, the company has 20.30 K employees. See our rating of the largest employees — is PHARMARON BEIJING H YC1 on this list?
Like other stocks, 17Q1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARON BEIJING H YC1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARON BEIJING H YC1 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARON BEIJING H YC1 stock shows the sell signal. See more of PHARMARON BEIJING H YC1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.